NYSE:PTHS | Profit Breakdown | Pelthos Therapeutics Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2022-12-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$15.6M-$17.32M-$23.42M-$23.42M
2026-03-31$10.91M-$13.09M-$10.24M-$25.07M
2025-12-31$16.5M-$12M-$28.59M-$21.66M
2025-09-30$294,000.00-$15.36M-$16.7M-$16.24M
2025-06-30$0.00-$3.23M-$3.45M-$3.45M
2025-03-31$0.00-$1.83M-$1.97M-$1.97M
2024-12-31-$1.82M-$1.93M-$1.93M
2024-09-30-$2.05M-$1.7M-$1.7M
2024-06-30-$1.76M-$1.77M-$1.77M
2024-03-31-$1.93M-$2.56M-$2.56M
2023-12-31-$3.88M-$4.04M-$4.04M
2023-09-30-$1.29M-$1.42M-$1.42M
2023-06-30-$777,160.00-$953,347.00-$953,347.00
2023-03-31-$914,583.00-$966,561.00-$966,561.00

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$16.8M-$32.43M-$50.71M-$43.32M
2024-12-31$0.00-$7.57M-$7.96M-$7.96M
2023-12-31-$6.86M-$7.38M-$7.38M
2022-12-31-$2.32M-$2.46M-$2.46M